Insights

Washington – November 5, 2026: Crowell & Moring earned 60 rankings in the 2027 edition of Best Law Firms, including national recognition in 18 practice areas and 41 regional rankings across seven markets.

WASHINGTON, D.C. – October 22, 2026: Crowell & Moring has added Jeff McSorley as a partner in its industry-leading Health Care Group in Washington, D.C. McSorley joins the firm from the U.S. Department of Justice (DOJ), where he served for the past decade as a senior trial counsel in the Civil Division’s Commercial Litigation Branch, Fraud Section.

Washington – August 20, 2026: The Best Lawyers in America® has recognized 57 of the firm's attorneys in its 2027 edition, a testament to the firm's deep bench of legal talent across practices and offices nationwide. In addition, 29 attorneys have been named to the Best Lawyers: Ones to Watch® list, recognizing outstanding attorneys earlier in their careers. 

The Centers for Medicare and Medicaid Services (CMS) is proposing significant changes to the way Affordable Care Act (ACA) health insurance exchanges verify consumer eligibility before federal subsidies are made available.  

The U.S. Food & Drug Administration (FDA) recently issued final guidance — Regulatory Considerations for Prescription Drug Use-Related Software (PDURS) — to address when and how software disseminated by (or on behalf of) sponsors fits into existing drug-labeling requirements. The agency describes this as a response to longstanding uncertainty and a push toward a clearer, more consistent approach across FDA’s drug and device centers. 

On October 29, 2026, the U.S. Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) issued a 350-page final rule requiring providers of pharmacy benefit management services and their affiliated brokers and consultants to disclose fees and compensation received to fiduciaries of covered large, self-insured ERISA group health plans. According to DOL’s accompanying fact sheet, the disclosures will give employers more visibility into the payments PBMs may receive from various sources and help fiduciaries evaluate and monitor arrangements over time. 

Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond.

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:

The Federal Trade Commission continued its active enforcement agenda this week, targeting deceptive pricing practices across the healthcare, automotive, and retail sectors. The agency also took action against a martial arts franchisor for misleading earnings claims, secured a Robinson-Patman Act resolution involving wholesale T-shirt distributors, and distributed millions of dollars in consumer refunds stemming from prior settlements. These stories and more after the jump.

Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. See our State Attorneys General page for more insights. Below are the updates from September 18-23, 2026:

This week the Federal Trade Commission (FTC) issued a statement regarding the acquisition of Fairfield Medical Center by Adena Health, extended the public comment period on its proposed enforcement policy statement regarding personalized pricing, and announced a settlement with a payment processor to implement merchant screening practices and pay millions over charges of facilitating merchant fraud. More on these stories after the jump.

Hosts Jason Crawford and Agustin Orozco are joined by special guest Jeff McSorely to discuss the Health Care False Claims Act Self-Disclosure Pilot Program. This novel program allows eligible health care providers, suppliers, manufacturers, and payors to self-disclose potential civil FCA violations that were previously unknown to the federal government. "Let's Talk FCA" is Crowell & Moring’s podcast covering the latest developments with the False Claims Act.

Hosts Megan Beaver and Savanna Williams talk to Alice Hall-Partyka and Tai Williams about the rapidly evolving legal and regulatory landscape surrounding gender-affirming care. The conversation covers the federal Medicaid and CHIP rule that took effect October 13, 2026, which prohibits the use of federal matching funds for sex-rejecting procedures provided to minors, the varying state responses to that rule, and an ongoing legal challenge filed by Illinois and a coalition of states in the District of Massachusetts. The episode also addresses the Department of Justice’s wave of False Claims Act settlements with major hospital systems, FTC and state attorney general actions against medical professional societies, and key takeaways for health plans, providers, and their counsel navigating this shifting enforcement environment.

Host Megan Beaver talks to Alex Lucas and Jason Mayer about the No Surprises Act, a 2021 law designed to protect patients from unexpected medical bills, the federal independent dispute resolution process it created, the challenges that have plagued that process, and the new federal rule issued on June 4, 2026. The episode also covers the growing wave of enforcement litigation and what’s on the horizon for IDR.